top of page
Search
Glenn Hearson
Sep 6, 2023
Continuous respiratory rate and pulse oximetry monitoring using wearable sensors (RespiraSense)
We have recently commenced a new clinical trial testing a new device called RespiraSense which is worn on a patients chest and measures...
136
Glenn Hearson
Aug 21, 2023
COPD Case Finding In Nottingham and District: C-FIND COPD A Pilot study
We have now commenced a new research study supported by the NIHR Nottingham Biomedical Research Centre , NIHR Nottingham Clinical...
152
Glenn Hearson
Jul 27, 2023
Pizzas, BRC's and PhDs: An Informal Lunchtime Session for IMT's and above
Would you like to know more about NIHR Respiratory Medicine BRC, our research, training opportunities and what it's really like to do a...
29
Glenn Hearson
Jun 26, 2023
Could you help us design our asthma research? Be part Of Patient and Public Involvement in Research
We want to gather opinions on a project about how we can improve asthma care for people from different backgrounds. Dr Ireti Adejumo of...
72
Glenn Hearson
May 25, 2023
Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole
We have just commenced recruiting patients into a new trial which funded by an NIHR HTA Grant with Chief Investigator Professor Andrew...
74
Glenn Hearson
May 19, 2023
NIHR Nottingham BRC Respiratory Theme Recruits 1st patient in the UK into the AERIFY-3 Study
The respiratory theme of the NIHR Nottingham Biomedical Research Centre has recruited the first patient in the UK into the AERIFY-3...
111
Glenn Hearson
May 17, 2023
Respiratory Research Day: Universities of Nottingham, Leicester and @NottmBRCLung, @LeicesterBRC
We want to say a huge thank you to everyone who attended the University of Nottingham & University of Leicester Joint Respiratory...
115
Glenn Hearson
Apr 18, 2023
CRESCENDO: Study to Evaluate the Efficacy and Safety of AZD4831 in Moderate to Severe COPD
We have now commenced a new trial to assess the AstraZeneca drug AZD4831 for its efficacy and safety in patients with Chronic Obstructive...
594
bottom of page